We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

26 hedge funds and large institutions have $45.7K invested in CERo Therapeutics Warrants in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $28.6K → $45.7K (+$17.1K)

0.12% more ownership

Funds ownership: 2.13% → 2.26% (+0.12%)

0% more funds holding

Funds holding: 26 → 26 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.72K
2
PA
Parallel Advisors
California
+$705

Top Sellers

Rank Fund Capital Flow
1
Walleye Trading
Walleye Trading
New York
-$804
2
WA
Whitebox Advisors
Minnesota
-$25
3
CS
Clear Street
New York
-$11
4
Bank of America
Bank of America
North Carolina
-$4
5
TRCT
Tower Research Capital (TRC)
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$6.39K – – –
MI
2
MMCAP International
Cayman Islands
$5.44K – – –
PC
3
Periscope Capital
Ontario, Canada
$3.97K – – –
CSD
4
Clear Street Derivatives
New York
$3.89K – – –
SCM
5
Saba Capital Management
New York
$3.77K – – –
LA
6
Linden Advisors
New York
$3.33K – – –
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$2.8K +$2.72K +192,874 New
BOCH
8
Blue Owl Capital Holdings
New York
$2.25K – – –
CS
9
Clear Street
New York
$2.09K -$11 -800 -0.6%
QGA
10
Q Global Advisors
Texas
$2K – – –
CCM
11
Context Capital Management
California
$1.77K – – –
NAM
12
Nexpoint Asset Management
Texas
$1.58K – – –
PMAM
13
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
WCMNY
14
Westchester Capital Management (New York)
New York
$937 – – –
TCM
15
Tenor Capital Management
New York
$725 – – –
YCM
16
Yakira Capital Management
Connecticut
$725 – – –
PA
17
Parallel Advisors
California
$725 +$705 +50,000 New
WAM
18
Wolverine Asset Management
Illinois
$635 – – –
RCM
19
Rivernorth Capital Management
Florida
$362 – – –
WA
20
Whitebox Advisors
Minnesota
$337 -$25 -1,750 -7%
SSA
21
Schonfeld Strategic Advisors
New York
$217 – – –
Walleye Trading
22
Walleye Trading
New York
$193 -$804 -57,020 -81%
SRF
23
Silver Rock Financial
California
$177 – – –
Calamos Advisors
24
Calamos Advisors
Illinois
$166 – – –
DCM
25
Dupont Capital Management
Delaware
$166 – – –
1
2

CEROW Hedge Fund Activity: Q1 2025 in Review

26 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2025, worth a combined $45.7K — up 60% from $28.6K a quarter earlier.

Fund positioning in CEROW was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.72K. The largest seller was Walleye Trading, cutting an estimated $804.

  • 26 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $45.7K of CERo Therapeutics Warrants stock for Q1 2025, up 60% quarter-over-quarter.
  • 2 funds opened new CERo Therapeutics Warrants positions in Q1 2025 and 2 closed out, a net change of 0 holders.
  • The largest CERo Therapeutics Warrants buyer in Q1 2025 was Susquehanna International Group, an estimated $2.72K added.
  • The largest CERo Therapeutics Warrants seller in Q1 2025 was Walleye Trading, an estimated $804 sold.

Based on aggregated 13F filings for Q1 2025.